Santé et Bio technologies Cohortes

HOPE-Epidémiologie – Recherche épidémiologique en Hémato-Oncologie Pediatrique

HOPE-EPI

Keywords: cancer;enfant;facteurs de risque;effets iatrogènes;qualité de vie;accès aux soins;environnement;aprèscancer;radiations;biothèque virtuelle

Summary

The HOPE-EPI/CCOP infrastructure is dedicated to pediatric oncology research on (1) Environmental and genetic risk factors, (2) Evaluation of the management of childhood cancers in real life, (3) Iatrogenic effects of treatments, and, more generally, (4) Short, medium and long-term health of survivors and the determinants of their quality of life.

 

Major progress has been made during this latest period. The COHOPER cohort now includes more than 40,000 cases, with detailed treatments for 27,000 of them. PEDIART dosimetry is assigned to all cases who had radiotherapy since 2013 (> 3,500). We collected questionnaire data for 6,600 (47%) of the adult survivors and obtained controls from the Constances cohort. GEOCAP includes nearly 22,000 cases at diagnosis with 63,000 controls, and has addresses at birth for 2,800 cases born since 2010 and 12,000 birth controls. We assessed residential exposures to agricultural activities, magnetic fields and air pollution. All our data is standardized and subject to quality controls.

 

We have completed the regulatory procedures for compliance with the GDPR and obtained agreement for individual linkage with the SNDS. HOPE-EPI/CCOP now provides the community with relevant and reliable data, essential for evaluating and adapting care and prevention recommendations, in a context of constantly evolving treatments. We have opened the data last year and have just integrated France-Cohortes. We published 13 articles, and several external projects have already started.

 

Being attached to the National Childhood Cancer Registry is a considerable asset, which allows to benefit from its exhaustiveness, basic data and quality data collection practices. Individual linkage with the SNDS will also be a tremendous asset. Such epidemiological monitoring of childhood cancer survivors, without selection bias, on a large country and a national scale, makes HOPE-EPI/CCOP unique and particularly powerful among existing infrastructures worldwide.

 

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

General informations

Acronym: HOPE-EPI
Reference Number: 10-COHO-0009
Project Region: Île-de-France
Discipline: 5 - Bio Med
PIA investment: 6,074,370 €
Start date: February 2011
End date: December 2024

Project coordination : Jacqueline CLAVEL
Email: jacqueline.clavel@inserm.fr

Consortium du projet

Etablissement coordinateur : Université Paris Cité
Partenaire(s) : Centre anticancereux L. Bérard, Université d'Aix-Marseille, INSERM Délégation Paris IDF Centre-Nord (Paris 5), Institut de Cancérologie de Lorraine

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter